Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening lead compounds for QT interval prolongation.

R Netzer1, A Ebneth, U Bischoff

  • 1GENION Forschungsgesellschaft mbH Abteistrasse 57 20149, Hamburg, Germany

Drug Discovery Today
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus.

Stem cell research·2021
Same author

Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.

European psychiatry : the journal of the Association of European Psychiatrists·2017
Same author

Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format.

Journal of biomolecular screening·2016
Same author

Regulation of excitability by potassium channels.

Results and problems in cell differentiation·2007
Same author

Rate-limiting reactions determining different activation kinetics of Kv1.2 and Kv2.1 channels.

The Journal of membrane biology·2004
Same author

Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation.

Clinical genetics·2004

Early detection of drug-induced cardiotoxicity, like QT prolongation, is crucial. Utilizing electrophysiological and high-throughput assays for cardiac ion channels aids preclinical safety evaluation, preventing hazardous drug side effects.

Area of Science:

  • Pharmacology
  • Cardiovascular Toxicology
  • Drug Discovery

Background:

  • Late detection of cardiotoxicity, including QT prolongation, significantly hinders drug development and increases costs.
  • Undetected cardiotoxic side effects in new drugs pose serious risks, potentially causing lethal cardiac arrhythmias in patients.

Purpose of the Study:

  • To emphasize the need for early-stage testing of potential cardiotoxic side effects during drug development.
  • To highlight the utility of available electrophysiological and high-throughput assays for preclinical safety evaluation.

Main Methods:

  • Utilizing electrophysiological test systems for cloned human cardiac ion channels.
  • Employing cellular-based fluorometric high-throughput assays for assessing compound cardiotoxicity.

Related Experiment Videos

Main Results:

  • These advanced test systems provide essential tools for preclinical drug safety assessment.
  • Facilitating the identification of cardiotoxic compounds early in the development pipeline.

Conclusions:

  • Early identification of cardiotoxicity is vital for efficient and safe drug discovery.
  • Electrophysiological and high-throughput assays are key to evaluating the preclinical safety of novel compounds.